Company Overview of Apexigen Inc.
Apexigen Inc. operates as a biopharmaceutical product development company. It focuses on the development of product candidates for life-threatening and difficult to treat diseases. The company’s products include humanized antibodies for cancer, inflammatory diseases, and ophthalmic diseases. It discovers and develops rabbit-derived humanized monoclonal antibodies. The company was founded in 2010 and is based in Burlingame, California.
863 Mitten Road
Burlingame, CA 94010-1303
Founded in 2010
Key Executives for Apexigen Inc.
Chief Executive Officer, President and Director
Vice President of Finance
Vice President of Business Development
Director of Preclinical Development and Clinical Research
Vice President of Clinical Development
Compensation as of Fiscal Year 2015.
Apexigen Inc. Key Developments
Apexigen Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 09:45 AM
Dec 8 15
Apexigen Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 09:45 AM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States.
Apexigen, Inc. Announces the Initiation of A Phase 1 Clinical Trial of APX005M
Jun 16 15
Apexigen Inc. announced the initiation of a Phase 1 clinical trial of APX005M, the company's lead proprietary anticancer program. APX005M is an immuno-activating monoclonal antibody targeting CD40, a receptor that plays a central role in the regulation of antigen presentation functions and tumor-specific T cell response. The trial is a Phase 1, open-label dose-escalation study of APX005M in adults with solid tumors that is intended to establish the maximum tolerated dose, the pharmacokinetic profile and the overall safety and tolerability of APX005M. The study will also seek evidence of activation of the immune system in response to treatment and preliminary assessment of clinical response.
Apexigen, Inc. Appoints Ovid C. Trifan as Vice President, Clinical Development and Amy Wong as Vice President, Finance
Oct 15 14
Apexigen Inc. announced the appointments of Ovid C. Trifan, MD, PhD as Vice President, Clinical Development and Amy Wong as Vice President, Finance. Dr. Trifan previously held the position of Senior Medical Director in the Clinical Science group at Onyx Pharmaceuticals. Ms. Wong previously held the position of Vice President, Finance, Human Resources and Operations at Tobi.com.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|